{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:36:27Z","timestamp":1777545387993,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ymgme.2011.06.018","type":"journal-article","created":{"date-parts":[[2011,7,5]],"date-time":"2011-07-05T08:25:02Z","timestamp":1309854302000},"page":"325-337","source":"Crossref","is-referenced-by-count":73,"title":["Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis"],"prefix":"10.1016","volume":"104","author":[{"given":"Brian R.","family":"Vuillemenot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan R.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Tiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Kanazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Sohar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhea","family":"Cahayag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Keve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Koren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Bunting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie S.","family":"Tsuruda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2011.06.018_bb0005","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"Sleat","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2011.06.018_bb0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0167-4838(98)00012-0","article-title":"Purification and characterisation of a tripeptidyl aminopeptidase I from rat spleen","volume":"1384","author":"Vines","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2011.06.018_bb0015","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbadis.2006.05.006","article-title":"Molecular genetics of the NCLs \u2014 status and perspectives","volume":"1762","author":"Siintola","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2011.06.018_bb0020","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"Jalanko","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2011.06.018_bb0025","article-title":"The Neuronal Ceroid Lipofuschinoses (Batten Disease)","year":"2011"},{"key":"10.1016\/j.ymgme.2011.06.018_bb0030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/01.wnl.0000267885.47092.40","article-title":"Neurological deterioration in late infantile neuronal ceroid lipofuscinosis","volume":"69","author":"Worgall","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2011.06.018_bb0035","series-title":"Fabry Disease: Perspectives from 5 Years of FOS","article-title":"Enzyme replacement therapy \u2014 a brief history","author":"Neufeld","year":"2006"},{"key":"10.1016\/j.ymgme.2011.06.018_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3912\/OJIN.Vol13No01Man03","article-title":"An overview of enzyme replacement therapy for lysosomal storage diseases","volume":"13","author":"Bailey","year":"2008","journal-title":"Online J. Issues Nurs."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ymgme.2008.07.002","article-title":"Enzyme replacement therapy in Fabry disease: comparison of agalsidase alfa and agalsidase beta","volume":"95","author":"Mehta","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0050","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3928\/00904481-20090723-09","article-title":"Current enzyme replacement therapy for the treatment of lysosomal storage diseases","volume":"38","author":"Lim-Melia","year":"2009","journal-title":"Pediatr. Ann."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0055","first-page":"S63","article-title":"Enzyme replacement therapy for the management of the mucopolysaccharidoses","volume":"47","author":"Wraith","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/0264-6021:3570049","article-title":"Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis","volume":"357","author":"Lin","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/187152709788680652","article-title":"Blood\u2013brain barrier transport of drugs for the treatment of brain diseases","volume":"8","author":"Gabathuler","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ymgme.2011.06.018_bb0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ymgme.2009.07.013","article-title":"Effect of cisternal sulfamidase delivery in MPS IIIA Huntaway dogs \u2014 a proof of principle study","volume":"98","author":"Hemsley","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2011.04.014","article-title":"Enzyme replacement reduces neuropathology in MPS IIIA dogs","author":"Crawley","year":"2011","journal-title":"Neurobiol. Disease"},{"key":"10.1016\/j.ymgme.2011.06.018_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ymgme.2005.04.013","article-title":"Penetration, diffusion, and uptake of recombinant human alpha-l-iduronidase after intraventricular injection into the rat brain","volume":"86","author":"Belichenko","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ymgme.2006.12.012","article-title":"Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid","volume":"91","author":"Dickson","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0095","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0100","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ymgme.2009.10.002","article-title":"Repeated intrathecal injections of recombinant human 4-sulphatase remove dural storage in mature mucopolysaccharidosis VI cats primed with a short-course tolerisation regimen","volume":"99","author":"Auclair","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0105","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jhered\/esi088","article-title":"Characterization of candidate genes for neuronal ceroid lipofuscinosis in dog","volume":"96","author":"Dr\u00f6gem\u00fcller","year":"2005","journal-title":"J. Hered."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymgme.2006.02.016","article-title":"A frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis","volume":"89","author":"Awano","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0115","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1167\/iovs.08-1712","article-title":"Retinal pathology in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"49","author":"Katz","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0120","doi-asserted-by":"crossref","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","article-title":"A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration","volume":"24","author":"Sleat","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ymgme.2008.01.014","article-title":"Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis","volume":"94","author":"Sleat","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2011.130","article-title":"Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis","author":"Xu","year":"2011","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.ymgme.2011.06.018_bb0135","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1074\/jbc.M507336200","article-title":"Determination of the substrate specificity of tripeptidyl-peptidase I using combinatorial peptide libraries and development of improved fluorogenic substrates","volume":"281","author":"Tian","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0140","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/clinchem\/46.7.1005","article-title":"Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatin-insensitive protease assays","volume":"46","author":"Sohar","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0145","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2460\/ajvr.2005.66.67","article-title":"Assessment of retinal function and characterization of lysosomal storage body accumulation in the retinas and brains of Tibetan Terriers with ceroid-lipofuscinosis","volume":"66","author":"Katz","year":"2005","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0150","first-page":"723","article-title":"Quantitation of Mr 46000 and Mr 300000 mannose 6-phosphate receptors in human cells and tissues","volume":"23","author":"Wenk","year":"1991","journal-title":"Biochem. Int."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0155","article-title":"Intracisternal enzyme replacement therapy in lysosomal storage diseases: routes of absorption into brain","author":"Jolly","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0160","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1091\/mbc.8.12.2631","article-title":"Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation","volume":"12","author":"Raposo","year":"1997","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ymgme.2011.06.018_bb0165","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6807-3-8","article-title":"A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases","volume":"3","author":"Wlodawer","year":"2003","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0170","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1172\/JCI41911","article-title":"Trafficking of immune cells in the central nervous system","volume":"120","author":"Wilson","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0175","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1073\/pnas.0305480101","article-title":"Successful induction of immune tolerance to enzyme replacement therapy in a canine mucopolysaccharidosis I","volume":"101","author":"Kakkis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2011.06.018_bb0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1022998010833","article-title":"Induction of tolerance to a recombinant human enzyme, acid alpha-glucosidase, in enzyme deficient knockout mice","volume":"12","author":"Raben","year":"2003","journal-title":"Transgenic Res."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0185","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1167\/iovs.04-0601","article-title":"Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration","volume":"46","author":"Gaudreault","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0190","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1167\/iovs.04-0087","article-title":"Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid","volume":"47","author":"Kim","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(99)02089-2","article-title":"Comparison of cytosine arabinoside delivery to rat brain by intravenous, intrathecal, intraventricular and intraparenchymal routes of administration","volume":"856","author":"Groothuis","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0200","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2006.09.7311","article-title":"Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma","volume":"25","author":"Rubenstein","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0205","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1096\/fj.06-6169com","article-title":"Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy","volume":"21","author":"Lee","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2011.06.018_bb0210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.expneurol.2008.10.021","article-title":"Intracerebroventricular infusion of acid sphingomyelinase corrects the CNS manifestations in a mouse model of Niemann\u2013Pick A disease","volume":"215","author":"Dodge","year":"2009","journal-title":"Exper. Neurol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719211002058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719211002058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:23:50Z","timestamp":1686183830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719211002058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1096719211002058"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2011.06.018","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}